{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:14:26Z","timestamp":1792178066396,"version":"4.4.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.tips.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T04:49:57Z","timestamp":1359434997000},"page":"167-177","source":"Crossref","is-referenced-by-count":387,"title":["The promise of N-acetylcysteine in neuropsychiatry"],"prefix":"10.1016","volume":"34","author":[{"given":"Michael","family":"Berk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gin S.","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2013.01.001_bib0005","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-Acetylcysteine for antioxidant therapy: pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.tips.2013.01.001_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.biopsych.2012.04.001","article-title":"Translating the rosetta stone of N-acetylcysteine","volume":"71","author":"Dean","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-Acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0600","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/14734220601142878","article-title":"N-Acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology","volume":"6","author":"Arakawa","year":"2007","journal-title":"Cerebellum"},{"key":"10.1016\/j.tips.2013.01.001_bib0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroscience.2008.06.010","article-title":"Blunted cysteine\u2013glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking","volume":"155","author":"Kau","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2013.01.001_bib0025","doi-asserted-by":"crossref","first-page":"736837","DOI":"10.1155\/2012\/736837","article-title":"Glutathione homeostasis and functions: potential targets for medical interventions","volume":"2012","author":"Lushchak","year":"2012","journal-title":"J. Amino Acids"},{"key":"10.1016\/j.tips.2013.01.001_bib0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pbb.2011.04.015","article-title":"Glutamatergic medications for the treatment of drug and behavioral addictions","volume":"100","author":"Olive","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tips.2013.01.001_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","article-title":"N-Methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?","volume":"83","author":"Kantrowitz","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tips.2013.01.001_bib0040","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1523\/JNEUROSCI.1007-05.2005","article-title":"Cystine\/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking","volume":"25","author":"Moran","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/MN:24:1-3:107","article-title":"Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death","volume":"24","author":"Sattler","year":"2001","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2013.01.001_bib0050","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.22-20-09134.2002","article-title":"The origin and neuronal function of in vivo nonsynaptic glutamate","volume":"22","author":"Baker","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0605","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1301532","article-title":"Contribution of cystine-glutamate antiporter to the psychotomimetic effects of phencyclidine","volume":"33","author":"Baker","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cysteine\u2013glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3940(91)90045-U","article-title":"Oxidized glutathione modulates N-methyl-d-aspartate- and depolarization-induced increases in intracellular Ca2+ in cultured rat forebrain neurons","volume":"133","author":"Gilbert","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2013.01.001_bib0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0026-895X(25)08878-9","article-title":"Stimulation of N-methyl-d-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione","volume":"41","author":"Leslie","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1023\/A:1027377605054","article-title":"Glutathione is an endogenous ligand of rat brain N-methyl-d-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors","volume":"22","author":"Varga","year":"1997","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","article-title":"Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia","volume":"137","author":"Steullet","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2013.01.001_bib0080","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11064-007-9315-z","article-title":"Modulation of [3H]dopamine release by glutathione in mouse striatal slices","volume":"32","author":"Janaky","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0085","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/bmc.1171","article-title":"The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography","volume":"23","author":"Gere-Paszti","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.tips.2013.01.001_bib0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10863-009-9257-z","article-title":"The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease","volume":"41","author":"Hastings","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.tips.2013.01.001_bib0095","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/sj.npp.1300512","article-title":"Protective effects of N-acetyl-l-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine","volume":"29","author":"Hashimoto","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1124\/mol.111.074120","article-title":"AC927, a sigma receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells","volume":"81","author":"Kaushal","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jnr.10308","article-title":"Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells","volume":"69","author":"Hirrlinger","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0110","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1073\/pnas.172399499","article-title":"Appraising the brain's energy budget","volume":"99","author":"Raichle","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.01.001_bib0115","doi-asserted-by":"crossref","first-page":"e17514","DOI":"10.1371\/journal.pone.0017514","article-title":"Scaling of brain metabolism with a fixed energy budget per neuron: implications for neuronal activity, plasticity and evolution","volume":"6","author":"Herculano-Houzel","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2013.01.001_bib0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tips.2013.01.001_bib0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pnpbp.2007.10.002","article-title":"Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant\u2013antioxidant status","volume":"32","author":"Selek","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","article-title":"Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia","volume":"11","author":"Wang","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.tips.2013.01.001_bib0135","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia","volume":"32","author":"Kunz","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.schres.2007.01.030","article-title":"DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia","volume":"93","author":"Buttner","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","article-title":"DNA damage in bipolar disorder","volume":"153","author":"Andreazza","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1503\/jpn.090083","article-title":"Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness","volume":"35","author":"Che","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archpsyc.61.3.300","article-title":"Molecular evidence for mitochondrial dysfunction in bipolar disorder","volume":"61","author":"Konradi","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0160","first-page":"189","article-title":"Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder","volume":"31","author":"Sun","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fgene.2012.00103","article-title":"Mitochondrial mutations and polymorphisms in psychiatric disorders","volume":"3","author":"Sequeira","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.tips.2013.01.001_bib0170","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: a case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archpsyc.1959.03590040028002","article-title":"Blood glutathione and eosinophil levels and hospital adjustment scale in chronic schizophrenia","volume":"1","author":"Altschule","year":"1959","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0180","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","article-title":"Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients","volume":"38","author":"Altuntas","year":"2000","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.tips.2013.01.001_bib0185","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1172\/JCI100639","article-title":"The lactic acid and glutathione content of the blood of schizophrenic patients","volume":"13","author":"Looney","year":"1934","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2013.01.001_bib0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archneurpsyc.1952.02320130070006","article-title":"Blood glutathione level in mental disease before and after treatment","volume":"67","author":"Altschule","year":"1952","journal-title":"AMA Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","article-title":"Antioxidant enzyme activities and oxidative stress in affective disorders","volume":"19","author":"Erkan Ozcan","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"Bilici","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2013.01.001_bib0205","first-page":"263","article-title":"3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder","volume":"34","author":"Andreazza","year":"2009","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jad.2010.12.019","article-title":"Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT","volume":"131","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2013.01.001_bib0215","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.npp.1301624","article-title":"Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients","volume":"33","author":"Lavoie","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0225","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbr.2011.10.020","article-title":"Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder","volume":"226","author":"Kulak","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0230","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ntt.2012.04.009","article-title":"Effect of chronic glutathione deficiency on the behavioral phenotype of Gclm\u2212\/\u2212 knockout mice","volume":"34","author":"Chen","year":"2012","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.tips.2013.01.001_bib0235","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejphar.2010.09.035","article-title":"Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats","volume":"649","author":"Choy","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0240","first-page":"262","article-title":"N-Acetyl cysteine inhibits depletion of brain glutathione levels in rats: implications for schizophrenia","volume":"7","author":"Dean","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0245","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/jcb.22196","article-title":"Reactive oxygen species-induced cell death of rat primary astrocytes through mitochondria-mediated mechanism","volume":"107","author":"Wang","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.tips.2013.01.001_bib0250","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/npp.2011.109","article-title":"N-Acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72\/G30 transgenic mice","volume":"36","author":"Otte","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1165\/rcmb.2007-0447OC","article-title":"Oxidation of plasma cysteine\/cystine redox state in endotoxin-induced lung injury","volume":"40","author":"Iyer","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.tips.2013.01.001_bib0260","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2013.01.001_bib0265","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1089\/ars.2010.3830","article-title":"The cystine\/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets","volume":"15","author":"Vene","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.tips.2013.01.001_bib0270","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0006-3223(95)00598-6","article-title":"Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?","volume":"40","author":"Zorrilla","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0275","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0280","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.tips.2013.01.001_bib0285","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","article-title":"The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells","volume":"107","author":"Denicoff","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tips.2013.01.001_bib0290","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-\u03b1 in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0295","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","article-title":"Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon \u03b1-2b therapy","volume":"18","author":"Capuron","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tips.2013.01.001_bib0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.tips.2013.01.001_bib0305","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0310","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/pdi.2009.00073","article-title":"Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study","volume":"30","author":"Nascimento","year":"2010","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.tips.2013.01.001_bib0315","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1399-6576.2011.02492.x","article-title":"Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial","volume":"55","author":"Mahmoud","year":"2011","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.tips.2013.01.001_bib0320","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.burns.2011.09.011","article-title":"Effect of N-acetylcysteine treatment on oxidative stress and inflammation after severe burn","volume":"38","author":"Csontos","year":"2012","journal-title":"Burns"},{"key":"10.1016\/j.tips.2013.01.001_bib0325","doi-asserted-by":"crossref","first-page":"716458","DOI":"10.1155\/2008\/716458","article-title":"Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine","volume":"2008","author":"Chen","year":"2008","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.tips.2013.01.001_bib0330","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jnr.20087","article-title":"Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke","volume":"76","author":"Khan","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.tips.2013.01.001_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2012.08.008","article-title":"Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient mice","author":"Corona","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tips.2013.01.001_bib0610","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3109\/14767058.2011.632793","article-title":"Maternal N-acetyl-cysteine (NAC) protects the rat fetal brain from inflammatory cytokine responses to lipopolysaccharide (LPS)","volume":"25","author":"Beloosesky","year":"2012","journal-title":"J. Matern. Fetal Neonatal. Med."},{"key":"10.1016\/j.tips.2013.01.001_bib0345","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ana.21066","article-title":"N-Acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury","volume":"61","author":"Wang","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2013.01.001_bib0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1993.tb38050.x","article-title":"Molecular characterisation of NMDA and metabotropic glutamate receptors","volume":"707","author":"Masu","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tips.2013.01.001_bib0355","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/187152707780619326","article-title":"Gliogenesis and glial pathology in depression","volume":"6","author":"Rajkowska","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.tips.2013.01.001_bib0360","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1442-9071.2009.02000.x","article-title":"Effect of N-acetylcysteine on the early expression of inflammatory markers in the retina and plasma of diabetic rats","volume":"37","author":"Tsai","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.tips.2013.01.001_bib0365","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.expneurol.2011.10.025","article-title":"System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo","volume":"233","author":"Kigerl","year":"2012","journal-title":"Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2013.01.001_bib0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2008.07.011","article-title":"Glutamate transmission in addiction","volume":"56","author":"Kalivas","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0375","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(89)90045-3","article-title":"Blockade of \u201creverse tolerance\u201d to cocaine and amphetamine by MK-801","volume":"45","author":"Karler","year":"1989","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2013.01.001_bib0380","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2012.66","article-title":"N-Acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study","volume":"37","author":"Schmaal","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0385","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-011-2619-3","article-title":"Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine","volume":"222","author":"Chen","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2011.08.074","article-title":"Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats","volume":"196","author":"Alvaro-Bartolome","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.tips.2013.01.001_bib0395","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2131\/jts.28.455","article-title":"A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine","volume":"28","author":"Watanabe","year":"2003","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tips.2013.01.001_bib0400","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pathophys.2011.04.001","article-title":"d-Amphetamine-induced cytotoxicity and oxidative stress in isolated rat hepatocytes","volume":"18","author":"El-Tawil","year":"2011","journal-title":"Pathophysiology"},{"key":"10.1016\/j.tips.2013.01.001_bib0405","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1471-4159.2010.06794.x","article-title":"Cocaine causes memory and learning impairments in rats: involvement of nuclear factor \u03baB and oxidative stress, and prevention by topiramate","volume":"114","author":"Muriach","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.01.001_bib0410","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","article-title":"The role of cysteine\u2013glutamate exchange in nicotine dependence in rats and humans","volume":"65","author":"Knackstedt","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0415","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","article-title":"A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence","volume":"20","author":"Grant","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1521-0391.2009.00027.x","article-title":"N-Acetylcysteine (NAC) in young marijuana users: an open-label pilot study","volume":"19","author":"Gray","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.tips.2013.01.001_bib0425","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.2012.12010055","article-title":"A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents","volume":"169","author":"Gray","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0430","first-page":"167","article-title":"Effects of oral administration of N-acetyl-l-cysteine: a multi-biomarker study in smokers","volume":"11","author":"Van Schooten","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.tips.2013.01.001_bib0435","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"Larowe","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.tips.2013.01.001_bib0440","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/appi.ajp.164.7.1115","article-title":"Is cocaine desire reduced by N-acetylcysteine?","volume":"164","author":"LaRowe","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0445","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","article-title":"An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study","volume":"31","author":"Mardikian","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0450","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study","volume":"62","author":"Grant","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0455","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1176\/appi.neuropsych.20.4.390","article-title":"A psychological and neuroanatomical model of obsessive\u2013compulsive disorder","volume":"20","author":"Huey","year":"2008","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0465","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2008.10.004","article-title":"Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive\u2013compulsive disorder","volume":"33","author":"Ozdemir","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0470","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.pnpbp.2006.03.034","article-title":"Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive\u2013compulsive disorder","volume":"30","author":"Ersan","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0475","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pnpbp.2011.02.011","article-title":"Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence","volume":"35","author":"Camfield","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0480","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-Acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive\u2013compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.tips.2013.01.001_bib0485","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00406-006-0668-0","article-title":"Epidemiologic and clinical updates on impulse control disorders: a critical review","volume":"256","author":"Dell\u2019Osso","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.tips.2013.01.001_bib0490","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/10673220701298407","article-title":"Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome","volume":"15","author":"Grant","year":"2007","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0495","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.jcp.0000264976.86990.00","article-title":"N-Acetyl cysteine in the treatment of grooming disorders","volume":"27","author":"Odlaug","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0500","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archgenpsychiatry.2009.60","article-title":"N-Acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study","volume":"66","author":"Grant","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0505","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S1092852900023002","article-title":"Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting","volume":"14","author":"Berk","year":"2009","journal-title":"CNS Spectr."},{"key":"10.1016\/j.tips.2013.01.001_bib0510","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/mol.109.059865","article-title":"Glutamatergic (N-methyl-d-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?","volume":"77","author":"Marek","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tips.2013.01.001_bib0515","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2174\/092986709788803060","article-title":"A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice","volume":"16","author":"Dean","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tips.2013.01.001_bib0520","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-Acetyl cysteine as a glutathione precursor for schizophrenia \u2013 a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0525","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4088\/JCP.09m05741yel","article-title":"Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia","volume":"72","author":"Berk","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0530","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1080\/15622970903144004","article-title":"Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia","volume":"10","author":"Bulut","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0535","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-Acetyl cysteine for depressive symptoms in bipolar disorder \u2013 a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0540","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1590\/S1516-44462011000400011","article-title":"N-Acetylcysteine for major depressive episodes in bipolar disorder","volume":"33","author":"Magalhaes","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.tips.2013.01.001_bib0545","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2010.08.001","article-title":"N-Acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial","volume":"129","author":"Magalhaes","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tips.2013.01.001_bib0550","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1517\/14728222.2010.528394","article-title":"Oxidative pathways as a drug target for the treatment of autism","volume":"14","author":"Villagonzalo","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.tips.2013.01.001_bib0555","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2013.01.001_bib0560","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2012.03.021","article-title":"N-Acetyl-cysteine in the treatment of Parkinson's disease. What are we waiting for?","volume":"79","author":"Martinez-Banaclocha","year":"1999","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.tips.2013.01.001_bib0565","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2013.01.001_bib0570","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1533317508325093","article-title":"Efficacy of a vitamin\/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension","volume":"23","author":"Chan","year":"2008","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.tips.2013.01.001_bib0575","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","article-title":"Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","volume":"24","author":"Remington","year":"2009","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"10.1016\/j.tips.2013.01.001_bib0580","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI29444","article-title":"S-Nitrosothiols signal hypoxia-mimetic vascular pathology","volume":"117","author":"Palmer","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2013.01.001_bib0585","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1742-7843.2006.pto_377.x","article-title":"Facilitation action of N-acetylcysteine on the anticonvulsant effect of sodium valproate in mice","volume":"98","author":"Devi","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2013.01.001_bib0590","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.annemergmed.2004.05.014","article-title":"Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death","volume":"44","author":"Bailey","year":"2004","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.tips.2013.01.001_bib0595","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614713000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614713000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:43:16Z","timestamp":1745937796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614713000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":121,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0165614713000023"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2013.01.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}